News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medtronic, Inc. (MDT) Submits Pre-Market Approval Application to the FDA for the Talent(TM) Thoracic Stent Graft System



3/5/2007 1:41:35 PM

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) said today that it has submitted the final module of its pre-market approval (PMA) application to the U.S. Food and Drug Administration for approval to commercially market and sell the Talent™ Thoracic stent graft system. The Talent Thoracic stent graft provides a minimally-invasive treatment alternative to open surgery for patients who develop life-threatening aneurysms in the upper portion of the aorta, the body’s largest artery.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES